The Role of the Toxicologic Pathologist in the Post-Genomic Era
-
- MARONPOT Robert R.
- Maronpot Consulting, LLC, Raleigh, NC 27607, USA
書誌事項
- タイトル別名
-
- The Role of the Toxicologic Pathologist in the Post-Genomic Era<sup>#</sup>
この論文をさがす
説明
An era can be defined as a period in time identified by distinctive character, events, or practices. We are now in the genomic era. The pre-genomic era: There was a pre-genomic era. It started many years ago with novel and seminal animal experiments, primarily directed at studying cancer. It is marked by the development of the two-year rodent cancer bioassay and the ultimate realization that alternative approaches and short-term animal models were needed to replace this resource-intensive and time-consuming method for predicting human health risk. Many alternatives approaches and short-term animal models were proposed and tried but, to date, none have completely replaced our dependence upon the two-year rodent bioassay. However, the alternative approaches and models themselves have made tangible contributions to basic research, clinical medicine and to our understanding of cancer and they remain useful tools to address hypothesis-driven research questions. The pre-genomic era was a time when toxicologic pathologists played a major role in drug development, evaluating the cancer bioassay and the associated dose-setting toxicity studies, and exploring the utility of proposed alternative animal models. It was a time when there was shortage of qualified toxicologic pathologists. <br/>Continued on Full Text PDF
収録刊行物
-
- Journal of Toxicologic Pathology
-
Journal of Toxicologic Pathology 26 (2), 105-110, 2013
日本毒性病理学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001204414150656
-
- NII論文ID
- 130003362377
-
- NII書誌ID
- AN10232280
-
- COI
- 1:STN:280:DC%2BC3sfmslWisg%3D%3D
-
- ISSN
- 1881915X
- 09149198
-
- NDL書誌ID
- 024792318
-
- PubMed
- 23914052
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可